UnitedHealth Group Incorporated (NYSE:UNH) is Buckhead Capital Management LLC’s 7th Largest Position

Buckhead Capital Management LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,296 shares of the healthcare conglomerate’s stock after selling 132 shares during the quarter. UnitedHealth Group makes up approximately 2.3% of Buckhead Capital Management LLC’s holdings, making the stock its 7th largest holding. Buckhead Capital Management LLC’s holdings in UnitedHealth Group were worth $7,232,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $30,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $37,000. Friedenthal Financial acquired a new stake in shares of UnitedHealth Group in the third quarter worth approximately $51,000. DecisionPoint Financial LLC increased its position in UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the last quarter. Finally, Highline Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group during the 3rd quarter valued at $55,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, TD Cowen upped their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $531.31 on Friday. The stock has a market cap of $488.95 billion, a P/E ratio of 34.28, a P/E/G ratio of 1.45 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm’s 50-day simple moving average is $524.58 and its 200 day simple moving average is $563.71. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the business posted $5.83 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.